JFG
PLRX icon

Jefferies Financial Group’s Pliant Therapeutics PLRX Stock Holding History

Jefferies Financial Group’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,662
Closed -$257K – 1935
2023
Q1 		$257K Sell
9,662
-44,865
-82% -$1.28M ﹤0.01% 1276
2022
Q4 		$1.05M Buy
+54,527
New +$1.14M 0.01% 853

Other funds holding PLRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Jefferies Financial Group's PLRX Position: Q2 2023 in Review

Jefferies Financial Group sold out of Pliant Therapeutics (PLRX) in Q2 2023, closing a stake of 9,662 shares — an estimated $257K sold.

Jefferies Financial Group first reported a position in PLRX in Q4 2022 and held it in 2 quarters. The position peaked at $1.05M in Q4 2022. 144 funds tracked by Wall St. Rank hold PLRX as of Q2 2023.

  • Jefferies Financial Group reported no remaining Pliant Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 9,662 Pliant Therapeutics shares in Q2 2023, an estimated $257K.
  • Jefferies Financial Group first reported a position in Pliant Therapeutics in Q4 2022 and held it in 2 quarters.
  • Jefferies Financial Group's Pliant Therapeutics position peaked at $1.05M in Q4 2022.
  • 144 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2023.

Based on Jefferies Financial Group's 13F filing for Q2 2023, filed 14 Aug 2023.